ArticleScientific reports2026
Development and comparative evaluation of TaqMan real-time PCR assays for detecting Enterocytozoon hepatopenaei (EHP) in penaeid shrimp.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Enterocytozoon hepatopenaei (EHP) is a microsporidian that retards shrimp growth and threatens global aquaculture, making reliable, sensitive detection essential for surveillance and control. Herein, we compared six TaqMan real-time PCR assays targeting distinct EHP loci, including three published assays (SSU rDNA, β-tubulin, and cysteine desulfurase/NFS1), two unpublished internal Aquaculture Pathology Laboratory assays (DNA polymerase and ATP/ADP translocase), and a newly designed spore wall protein (SWP) assay. Assay development and validation followed the World Organisation for Animal Health (WOAH) framework, assessing analytical specificity, analytical sensitivity/limit of detection (LOD), repeatability, and reproducibility using defined plasmid DNA standards. All assays were specific for EHP, with no cross-reactivity to other crustacean pathogens causing enteric disease (e.g., NHP, AHPND, TPD) or systemic infections (e.g., IHHNV, WSSV nor with the crustacean microsporidian Perezia sp. or a novel intranuclear Enterocytozoon sp. The only exception was the SSU rDNA assay, which also amplified the novel intranuclear Enterocytozoon sp. All assays achieved an LOD of 10 copies/µL. Repeatability was strong (%CV < 1.65%) and reproducibility good (%CV < 5.70%); however, qPCR efficiency fell outside the 90-110% range for the β-tubulin and ATP/ADP translocase assays in repeatability tests, and for the β-tubulin, NFS1, and ATP/ADP translocase assays in reproducibility tests. These three assays also showed relatively lower reproducibility, with occasional reductions in linearity (R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.